How do we identify and treat patients with BRAF-mutated mCRC?

Dr. Scott Kopetz (USA) led a very interesting and interactive GI CONNECT virtual Experts Knowledge Share which addressed the question ‘How do we identify and treat patients with BRAF-mutated mCRC (metastatic colorectal cancer) today and tomorrow?’

Dr. Armin Gerger and Dr. Joleen Hubbard provided the US and European perspectives on this important topic.